Stravix® is a cryopreserved human placental tissue composed of umbilical amnion and Wharton’s jelly. Stravix retains the native collagen and hyaluronic acid-rich extracellular matrix (ECM), endogenous growth factors, and endogenous cells including epithelial cells, fibroblasts, and mesenchymal stem cells (MSCs) found in placental tissue.

Why Stravix?

Stravix is a living placental tissue for surgical applications. It serves as an anti-adhesion, anti- inflammatory, and antimicrobial wrap to aid natural wound repair. As a viable wrap for surgical procedures, Stravix conforms to injured tissue, can be sutured, and is arthroscopic and robotic procedure friendly. Stravix is manufactured using a proprietary process allowing the tissue to retain its native components.

Stravix Facts

  • Available in two sizes
  • 2-year shelf life at -75°C to -85°C
  • Minimal preparation required
  • Durable, conforming, and easy to manipulate
  • Defined as an HCT/P under Section 361 of the Public Health Service Act and 21 CFR Part 1271

Stravix preserves the native components of placental tissue

  • Viable endogenous cells
  • Variety of endogenous growth factors, cytokines, and peptides
  • Collagen and hyaluronic acid-rich ECM

Stravix can be used as a surgical covering or wrap for several procedures, including but not limited to:

  • Tendon Repair
  • Achilles Tendon Rupture
  • Bunionectomy
  • Hallux Rigidus Correction
  • Foot Amputations
  • Fibromatosis
  • Arthrodesis

Stravix Sizing


Stravix in Action:

A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular condition.